BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

9:04 AM
 | 
Dec 20, 2018
 |  BC Innovations  |  Translation in Brief

Beyond T cell counts

How functional TCR profiling could aid selection of cancer treatments

While strategies to increase the efficacy of immune checkpoint inhibitors have largely been focused on boosting overall T cell count in the tumor microenvironment, researchers at the Netherlands Cancer Institute (NKI) found that antigen specificity of the T cells must also be taken into account, and the team plans to form a spinout to develop the findings.

In a December letter published in Nature Medicine, the researchers found that in high-grade serous ovarian cancer...

Read the full 360 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$100 USD
More Info >